Kyowa Kirin Stock price
Compare with Peer Group
Is Kyowa Kirin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Kyowa Kirin Stock Analysis
Analyst Opinions
18 Analysts have issued a Kyowa Kirin forecast:
Analyst Opinions
18 Analysts have issued a Kyowa Kirin forecast:
Don't miss a Thing! We will send you all news about Kyowa Kirin directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Kyowa Kirin Stock News
Company Profile
Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.
| Head office | Japan |
| CEO | Dr. Miyamoto |
| Employees | 5,161 |
| Founded | 1949 |
| Website | www.kyowakirin.co.jp |


